Pharmacological Activities of Cotoneaster racemiflorus- A Review

Abstract Many compounds were isolated from Cotoneaster racemiflora included racemiside A; cotonoate A; cotonoate B;  7,8-dimethoxy-6-hydroxycoumarin; 3,3,4-Tri-o-methylellagic acid; cereotagloperoxide; scopoletin; β- sittosterol; ursolic acid;    β- sittosterol 3-o-β-D-glucopyranoside;  aromatic esters (cotonoates A and B); methyl 3,4-dihydroxy-5-methoxybenzoate; Racemiside, scopoletin, 7,8-dimethoxy-6-hydroxycoumarin, 3,3′,4′-tri-o-methylellagic acid,  cereotagloperoxide,   a manna-like substance (shir-khist); sugars and phenolic  compounds. The pharmacological investigation revealed that Cotoneaster racemiflora possessed antioxidant, cytotoxic,  radioprotective, mutagenic,  antimutagenic, antibacterial  and enzyme inhibitory activities.   In the current paper, the cemical constituents, pharmacological and therapeutic effects of Cotoneaster racemiflora are reviewed.

[Full Text: PDF]

Updated: May 6, 2017 — 9:33 am
© The Pharmaceutical and Chemical Journal Frontier Theme